934268-52-7

Basic information

• Product Name: (R)-1-PHENYLBUTYLAMINE HCL
• Synonyms: [(1R)-1-phenylbutyl]amine hydrochloride;(R)-1-Phenylbutan-1-amine hydrochloride
• CAS NO: 934268-52-7
• Molecular Formula: C10H16ClN
• Molecular Weight: 185.69374
• Mol File: 934268-52-7.mol
• Article Data: 8

Chemical Properties

• Appearance: /
• Storage Temp.: Inert atmosphere,Room Temperature
• CAS DataBase Reference: (R)-1-PHENYLBUTYLAMINE HCL(CAS DataBase Reference)
• NIST Chemistry Reference: (R)-1-PHENYLBUTYLAMINE HCL(934268-52-7)
• EPA Substance Registry System: (R)-1-PHENYLBUTYLAMINE HCL(934268-52-7)

Safety Data

• Hazardous Substances Data: 934268-52-7(Hazardous Substances Data)

Usage

Description

(R)-1-Phenylbutylamine HCL, with the molecular formula C10H15ClN, is an enantiomer of 1-phenylbutylamine, a colorless liquid with a fishy odor. (R)-1-PHENYLBUTYLAMINE HCL is characterized by its selective serotonin releasing properties, stimulant and entactogen effects, and increased solubility in water due to its HCL salt form. It is essential to handle (R)-1-Phenylbutylamine HCL with care, considering its potential for abuse and its impact on the central nervous system.

Uses

Used in Pharmaceutical Industry:
(R)-1-Phenylbutylamine HCL is used as a chiral building block for the synthesis of various pharmaceutical drugs. Its unique properties make it a valuable component in the development of medications targeting the central nervous system.
Used in Central Nervous System Applications:
(R)-1-Phenylbutylamine HCL is used as a selective serotonin releasing agent for applications related to the central nervous system. Its stimulant and entactogen properties contribute to its potential use in the treatment of certain neurological and psychiatric conditions.
Used in Research and Development:
(R)-1-Phenylbutylamine HCL is utilized as a research compound to study its effects on the central nervous system and explore its potential in the development of new medications and therapies. (R)-1-PHENYLBUTYLAMINE HCL's properties make it a promising candidate for further investigation and application in the field of neuroscience.

Upstream product

• 1034110-31-0 (R,S)-N-(tert-butyloxycarbonyl)-α-n-propylbenzylamine 
• 112342-79-7 n-butyrophenone oxime 
• 607729-51-1 (S)-N-2,4,6-trimethylbenzenesulfinyl benzaldehyde imine 
• 1315317-99-7 (S)-2,4,6-trimethyl-N-((S)-1-phenylbutyl)-benzenesulfinamide 
• 108-86-1 bromobenzene 
• 1218989-64-0 (S)-2-methyl-propane-2-sulfinic acid [(S)-1-phenyl-butyl]amide 
• 22135-49-5 (S)-1-phenylbutan-1-ol 
• 2941-19-7 (R)-1-phenylbutylamine 

Downstream Products

• 3789-60-4 (S)-1-amino-1-phenylbutane 

Relevant articles and documents

APPLICATIONS OF N6-SUBSTITUTED ADENOSINE DERIVATIVE AND N6-SUBSTITUTED ADENINE DERIVATIVE TO CALMING, HYPNOSES, CONVULSION RESISTANCE, EPILEPTIC RESISTANCE, PARKINSON DISEASE RESISTANCE, AND DEMENTIA PREVENTION AND TREATMENT

PROBLEM TO BE SOLVED: To prepare analgesics, hypnotic agents, anticonvulsant agents, antiepileptics, antiparkinson drugs, dementia prophylactics, and health care food. SOLUTION: The present invention relates to an N6-substituted adenosine derivative and an N6-substituted adenine derivative selected from the group consisting of specific compounds. The present invention also relates to a pharmaceutical composition at least comprising a therapeutically effective amount of the compounds and a pharmaceutically acceptable carrier. The invention further relates to the compounds used in preparation of analgesics, hypnotic agents, anticonvulsant agents, antiepileptics, antiparkinson drugs, dementia prophylactics, and health care food. COPYRIGHT: (C)2016,JPO&INPIT

Synthesis and optimization of novel (3S,5R)-5-(2,2-dimethyl-5-oxo-4- phenylpiperazin-1-yl)piperidine-3-carboxamides as orally active renin inhibitors

We report synthesis and optimization of a series of (3S,5R)-5-(2,2- dimethyl-5-oxo-4-phenylpiperazin-1-yl)piperidine-3-carboxamides as renin inhibitors. Chemical modification of P1, P2 and P 3 portions led to a promising 3

N6-SUBSTITUTED ADENOSINE DERIVATIVES, N6-SUBSTITUTED ADENINE DERIVATIVES AND USES THEREOF

The present invention provides N6-substituted adenosine derivatives and N6-substituted adenine derivatives, manufacturing methods thereof, a pharmaceutical composition comprising the said compounds above, and uses of of these compounds in manufacturing medicaments and health-care products for treating insomnia, convulsion, epilepsy, and Parkinson's diseases, and preventing and treating dementia.